The Lifetime Prevalence of Anxiety Disorders Among Patients with Irritable Bowel Syndrome
Open accessThe DOI matches its Crossref record; 7 of the 7 references it cites were found in a registry or an index.
Abstract
BACKGROUND: The prevalence of irritable bowel syndrome (IBS), the most common functional gastrointestinal disorder, ranges from 10% to 20% in the general population. It is estimated that from 40% to 90% of persons with a diagnosis of IBS suffer from mental disorders, mainly anxiety and depressive disorders. OBJECTIVES: The aim of the study was to assess the lifetime prevalence of anxiety disorders in IBS patients and to compare it with the prevalence of these disorders in a control group of patients with gastroesophageal reflux disease (GERD). MATERIAL AND METHODS: The study included 106 patients with IBS and 53 patients with GERD. IBS was diagnosed according to the Rome II criteria after a basic evaluation to exclude an organic disease. Anxiety disorders were diagnosed using the Composite International Diagnostic Interview (CIDI) in accordance with ICD-10 diagnostic criteria. RESULTS: Anxiety disorders during the patient's lifetime were diagnosed in 50 IBS patients (47%). Specific phobias occurred in 23.5% of them, social phobias in 10.4%, generalized anxiety disorder in 10.4%, panic disorder in 3.8% and agoraphobia in 8.5%. In the control group with GERD, anxiety disorders during the subject's lifetime were diagnosed in 30% of the group. The difference in the prevalence of anxiety disorders between patients with IBS and GERD was statistically significant (p<0.05). CONCLUSIONS: The lifetime prevalence of anxiety disorders in IBS patients was higher than in the control group with GERD (47% vs. 30%). The prevalence rate of anxiety disorders in the control group with GERD was similar to the prevalence rate in the general population.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
AGA technical review on irritable bowel syndrome.
Drossman, D. A., Camilleri, M., Mayer, E. A., & Whitehead, W. E. (2002) · Gastroenterology · doi:10.1053/gast.2002.37095 · Cited by 1,384
Whitehead, W. E., Palsson, O., & Jones, K. R. (2002) · Gastroenterology · doi:10.1053/gast.2002.32392 · Cited by 1,116 · cited 1×
“Psychiatric disorders are diagnosed among around 40–60% of IBS patients, and according to some sources the rate among IBS patients is as high as 90% [10–13].”
BackgroundWittchen, H.-U., Lachner, G., Wunderlich, U., & Pfister, H. (1998) · Social Psychiatry and Psychiatric Epidemiology · doi:10.1007/s001270050095 · Cited by 668 · cited 1×
“The CIDI is a highly structured diagnostic instrument for the diagnosis of mental disorders in accordance with the ICD-10 and DSM-IV classification systems [18–20].”
MethodPrevalence of Psychiatric Disorders in Patients with Irritable Bowel Syndrome
Lydiard, R. B., Fossey, M. D., Marsh, W., & Ballenger, J. C. (1993) · Psychosomatics · doi:10.1016/s0033-3182(93)71884-8 · Cited by 229 · cited 1×
“Psychiatric disorders are diagnosed among around 40–60% of IBS patients, and according to some sources the rate among IBS patients is as high as 90% [10–13].”
BackgroundIrritable bowel syndrome is strongly associated with generalized anxiety disorder: a community study
LEE, S., WU, J., MA, Y. L., TSANG, A., GUO, W. ‐., & SUNG, J. (2009) · Alimentary Pharmacology & Therapeutics · doi:10.1111/j.1365-2036.2009.04074.x · Cited by 136
Jarrett, M. E., Burr, R. L., Cain, K. C., Hertig, V., Weisman, P., & Heitkemper, M. M. (2003) · Digestive Diseases and Sciences · doi:10.1023/a:1021904216312 · Cited by 94 · cited 1×
“, whose study group included only women [35].”
BackgroundManagement of Irritable Bowel Syndrome
TORII, A., & TODA, G. (2004) · Internal Medicine · doi:10.2169/internalmedicine.43.353 · Cited by 49
Cited by
Zamani, M., Alizadeh‐Tabari, S., & Zamani, V. (2019) · Alimentary Pharmacology & Therapeutics · doi:10.1111/apt.15325 · Cited by 496
The mucosal immune system: master regulator of bidirectional gut-brain communications
Powell, N., Walker, M. M., & Talley, N. J. (2017) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/nrgastro.2016.191 · Cited by 379
Cassar, G. E., Knowles, S., Youssef, G. J., Moulding, R., Uiterwijk, D., Waters, L., & Austin, D. W. (2018) · Psychology, Health & Medicine · doi:10.1080/13548506.2018.1476722 · Cited by 40
“…Group IBS sufferers report high levels of psychological distress (i.e. anxiety, depression and stress; Ben-Ezra, Hamama-Raz, Palgi, & Palgi, 2015; Grzesiak et al., 2014; Hartono, Mahadeva, & Goh, 2012; Pinto-Sanchez et al., 2015) and poorer quality of life (QoL; encompassing emotional, social,…”
BackgroundAgainst the stream: generalised anxiety disorder (GAD) – a redundant diagnosis
Tyrer, P. (2018) · BJPsych Bulletin · doi:10.1192/bjb.2017.12 · Cited by 9
Metadata
- Authors
- Grzesiak, M., Beszłej, J. A., Mulak, A., Szechiński, M., Szewczuk-Bogusławska, M., Waszczuk, E., Kantorska, M., & Frydecka, D.
- Venue
- Advances in Clinical and Experimental Medicine
- Publisher
- Wroclaw Medical University
- Published
- 2014-12-30
- Volume
- 23
- Issue
- 6
- Pages
- 987-992
- ISSN
- 1899-5276 (ISSN-L)
- OpenAlex
- W2322916967
- Cited by
- 19
- References
- 7
- FWCI
- 1.43
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: The Lifetime Prevalence of Anxiety Disorders Among Patients with Irritable Bowel Syndrome. https://app.cochat.ai/papers/10.17219/acem/37356
- The paper
- Grzesiak, M., Beszłej, J. A., Mulak, A., Szechiński, M., Szewczuk-Bogusławska, M., Waszczuk, E., Kantorska, M., & Frydecka, D. (2014). The Lifetime Prevalence of Anxiety Disorders Among Patients with Irritable Bowel Syndrome. Advances in Clinical and Experimental Medicine. https://doi.org/10.17219/acem/37356
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.